SCHEMBL3403374

SCHEMBL3403374

Cc1nc(-c2cccc(OC(C)C)c2)sc1C(=O)N1CCN(C(C)C)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.52
HTR2C P28335 6/20 0.46
GAA P10253 2/20 0.44
HTT P42858 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 3/20 0.43
LMNA P02545 3/20 0.43
KDM4E B2RXH2 2/20 0.43
USP2 O75604 2/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
HPGD P15428 1/20 0.42
XDH P47989 1/20 0.42
THRA P10827 2/20 0.42
THRB P10828 2/20 0.42
ROCK1 Q13464 1/20 0.42
MGLL Q99685 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3402546 0.93 CNR1 (0.53) CNR1HTR2CKMT2AMEN1ALDH1A1
SCHEMBL3403913 0.89 CNR1 (0.49) CNR1HTR2CHTTKMT2AMEN1
SCHEMBL3404671 0.88 CNR1 (0.48) CNR1HTR2CKMT2AALDH1A1SMN1; SMN2
SCHEMBL3399805 0.87 CNR1 (0.56) CNR1HTR2CGAAKMT2AALDH1A1
SCHEMBL3400211 0.85 CNR1 (0.48) CNR1HTR2CGAAHTTKMT2A
SCHEMBL3404377 0.85 TRPM8 (0.57) CNR1HTR2CKMT2AALDH1A1SMN1; SMN2
SCHEMBL3399653 0.85 CNR1 (0.54) CNR1HTR2CKMT2AALDH1A1SMN1; SMN2
SCHEMBL3401781 0.85 CNR1 (0.70) CNR1HTR2CGAAKMT2AMEN1
SCHEMBL3404549 0.84 CNR1 (0.53) CNR1HTR2CGAAKMT2AMEN1
SCHEMBL3400865 0.84 CNR1 (0.55) CNR1HTR2CALDH1A1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues LIGAND PHARMACEUTICALS, INC. (US) 2010-11-25 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297035-A1 Thiazole Amides, Imidazole Amides and Related Analogues HRH3, HRH4, HRH2 CNR1 35/4885HTR2C 416/4885GAA 1659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.